Connect with us

Uncategorized

University of Cincinnati-designed probes provide researchers with more detailed data

The University of Cincinnati’s Jiajie Diao and Yujie Sun have a simple approach to research: Keep an open mind, and follow the data wherever it leads. …

Published

on

The University of Cincinnati’s Jiajie Diao and Yujie Sun have a simple approach to research: Keep an open mind, and follow the data wherever it leads. 

Credit: Photo/University of Cincinnati Cancer Center.

The University of Cincinnati’s Jiajie Diao and Yujie Sun have a simple approach to research: Keep an open mind, and follow the data wherever it leads. 

This means even accidental findings are taken seriously, and the path toward their goals is not always straight from point A to point B. This mindset has led to a fruitful collaboration, with the researchers recently publishing articles on new probes that provide more information on how cells function in the journals Chemical Science and Biosensors and Bioelectronics

Looking deeper into tissue 

Previous probes developed by the team focused on a specialized structure called a lysosome that acts as the “recycling center” within cells, reusing broken or malfunctioning materials for different purposes. Abnormal pH levels within lysosomes are associated with cellular malfunctions that can lead to diseases like cancer and Alzheimer’s disease. 

Two previous generations of probes provided increasingly more detailed information about lysosome acidity at the cellular level, but the short wavelengths of light that activated the probe were not strong enough to penetrate tissue. 

“We had to use shorter wavelengths to excite the probe, and normally it’s visible wavelengths, so their penetration is really limited,” said Diao, PhD, associate professor in the Department of Cancer Biology in UC’s College of Medicine. “We could not go deep, so it’s good for cellular imaging, but it’s not good for tissue or research in living organisms (in vivo).” 

The latest advancement from the researchers was to use two lower energy photons with a longer wavelength to activate the probes. Called two-photon imaging, the longer wavelengths can penetrate deeper so that research can be done on animal models and human tissue. 

Sun and Diao developed three two-photon probes that locate at different areas of cells and can be used to better visualize organelles, or specialized structures within cells. 

“It can be used for two-photon microscopy to show 3D images of cells, organoids and tissues,” said Sun, PhD, professor in UC’s Department of Chemistry. “We are developing new two-photon-absorbing fluorescent probes which are sensitive to various factors, such as pH, viscosity and ionic species.” 

“Many times, tissue or even in vivo measurement is more important than cellular,” Diao added. “This probe will illuminate individual organelles, and it’s much better than the commercial two-photon probes currently available.” 

Detailing individual cell viability 

Researchers testing new treatments for diseases like cancer measure cell viability, or whether or not a cell is dying or remains active, after coming into contact with a treatment. 

“When you give a treatment, the first thing you always check is the cell viability,” Diao said.  

Traditionally, cell viability was measured by looking at a large population of millions of cells at a time, which Diao said is like giving an entire group of students the same exam grade based on their average score. 

“As everyone can feel at some time, it’s unfair, because everyone is different,” Diao said. “And every cell is different.” 

Progress in the field of cell biology has led to new interest in measuring individual cell viability, which is like grading each student based on their own performance on the exam. This provides more specific insights to researchers by showing how different types of cells react to treatments being tested. 

When working on the previous probe that measured cells’ acidity levels, Diao and Sun created a control version that was not sensitive to changes in pH levels. Completely by accident, they found that even though this version of the probe was structurally similar, it behaved differently, locating itself at different organelles. 

The new probe initially stains the cell’s mitochondria, which acts as the power plant providing energy to the cell. But when the cell is damaged, the probe moves itself and stains the nucleus, which contains the cell’s genetic material.  

“Eventually the signal on the mitochondria will start getting dim, and the signal on the nucleus will get stronger, so by measuring the color intensity ratio between the mitochondria and the nucleus, we can quantitatively assess the viability of individual cells,” Diao said. “That’s a very new concept. Nobody has done this before.” 

Long term, the team hopes the probe can be used to learn more about biological differences that affect whether a cell is immediately killed by a treatment or develops resistance and is unaffected. 

“There must be something different,” Diao said. “We want to kill the bad cells and we want to make the good cells live longer. We want to assist that at an individual cell level.” 

Sun said they will also work to extend what is known as the probe’s spectral window, or the maximum wavelength that can be used to activate the probe. 

“Because longer wavelength photons have better tissue penetration, we will be able to see deeper,” Sun said. 

Successful collaboration 

Sun and Diao are the codirectors of UC’s Center for Chemical Imaging in Biomedicine, which has an aim of pushing the boundaries of imaging through developing new methods, probes and equipment.  

Since joining forces, the duo has been prolific in publishing research and making advancements. Diao credits their joint mindset of not having any preconceived notions of where the research may lead for their success.

“I think the most important thing is always keeping an open mind, communicating frequently and not getting limited,” he said. “We always say data is data. Many times the biggest fight will be the fight between some preset imagination.” 

With larger goals always in mind, the research team constantly adjusts expectations and goals when they see an opportunity for tangible progress.  

Diao noted they originally started working together with the aim of immediately developing a two-photon probe, but they didn’t have the right experience. Rather than toiling away aimlessly, they switched gears, developed cellular probes and gained the knowledge needed to create the two-photon probes. 

Sun said another key aspect of the partnership is chemistry graduate student Rui Chen, who Diao and Sun co-advise. 

“Rui has been the bridge between our groups, and therefore Jiajie is fully aware of the progress we are making in my lab,” Sun said. “The complementary expertise between our two groups really makes us a great team to work synergistically together. I’m optimistic about our future achievements in bioimaging.” 


Read More

Continue Reading

Uncategorized

Aging at AACR Annual Meeting 2024

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging…

Published

on

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals

Credit: Impact Journals

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals

Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2024 from April 5-10 at the San Diego Convention Center in San Diego, California. This year, the AACR meeting theme is “Inspiring Science • Fueling Progress • Revolutionizing Care.”

Visit booth #4159 at the AACR Annual Meeting 2024 to connect with members of the Aging team.

About Aging-US:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed and archived by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com​​ and connect with us:

  • Aging X
  • Aging Facebook
  • Aging Instagram
  • Aging YouTube
  • Aging LinkedIn
  • Aging SoundCloud
  • Aging Pinterest
  • Aging Reddit

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.


Read More

Continue Reading

Uncategorized

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

One month after the inflation outlook tracked…

Published

on

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

One month after the inflation outlook tracked by the NY Fed Consumer Survey extended their late 2023 slide, with 3Y inflation expectations in January sliding to a record low 2.4% (from 2.6% in December), even as 1 and 5Y inflation forecasts remained flat, moments ago the NY Fed reported that in February there was a sharp rebound in longer-term inflation expectations, rising to 2.7% from 2.4% at the three-year ahead horizon, and jumping to 2.9% from 2.5% at the five-year ahead horizon, while the 1Y inflation outlook was flat for the 3rd month in a row, stuck at 3.0%. 

The increases in both the three-year ahead and five-year ahead measures were most pronounced for respondents with at most high school degrees (in other words, the "really smart folks" are expecting deflation soon). The survey’s measure of disagreement across respondents (the difference between the 75th and 25th percentile of inflation expectations) decreased at all horizons, while the median inflation uncertainty—or the uncertainty expressed regarding future inflation outcomes—declined at the one- and three-year ahead horizons and remained unchanged at the five-year ahead horizon.

Going down the survey, we find that the median year-ahead expected price changes increased by 0.1 percentage point to 4.3% for gas; decreased by 1.8 percentage points to 6.8% for the cost of medical care (its lowest reading since September 2020); decreased by 0.1 percentage point to 5.8% for the cost of a college education; and surprisingly decreased by 0.3 percentage point for rent to 6.1% (its lowest reading since December 2020), and remained flat for food at 4.9%.

We find the rent expectations surprising because it is happening just asking rents are rising across the country.

At the same time as consumers erroneously saw sharply lower rents, median home price growth expectations remained unchanged for the fifth consecutive month at 3.0%.

Turning to the labor market, the survey found that the average perceived likelihood of voluntary and involuntary job separations increased, while the perceived likelihood of finding a job (in the event of a job loss) declined. "The mean probability of leaving one’s job voluntarily in the next 12 months also increased, by 1.8 percentage points to 19.5%."

Mean unemployment expectations - or the mean probability that the U.S. unemployment rate will be higher one year from now - decreased by 1.1 percentage points to 36.1%, the lowest reading since February 2022. Additionally, the median one-year-ahead expected earnings growth was unchanged at 2.8%, remaining slightly below its 12-month trailing average of 2.9%.

Turning to household finance, we find the following:

  • The median expected growth in household income remained unchanged at 3.1%. The series has been moving within a narrow range of 2.9% to 3.3% since January 2023, and remains above the February 2020 pre-pandemic level of 2.7%.
  • Median household spending growth expectations increased by 0.2 percentage point to 5.2%. The increase was driven by respondents with a high school degree or less.
  • Median year-ahead expected growth in government debt increased to 9.3% from 8.9%.
  • The mean perceived probability that the average interest rate on saving accounts will be higher in 12 months increased by 0.6 percentage point to 26.1%, remaining below its 12-month trailing average of 30%.
  • Perceptions about households’ current financial situations deteriorated somewhat with fewer respondents reporting being better off than a year ago. Year-ahead expectations also deteriorated marginally with a smaller share of respondents expecting to be better off and a slightly larger share of respondents expecting to be worse off a year from now.
  • The mean perceived probability that U.S. stock prices will be higher 12 months from now increased by 1.4 percentage point to 38.9%.
  • At the same time, perceptions and expectations about credit access turned less optimistic: "Perceptions of credit access compared to a year ago deteriorated with a larger share of respondents reporting tighter conditions and a smaller share reporting looser conditions compared to a year ago."

Also, a smaller percentage of consumers, 11.45% vs 12.14% in prior month, expect to not be able to make minimum debt payment over the next three months

Last, and perhaps most humorous, is the now traditional cognitive dissonance one observes with these polls, because at a time when long-term inflation expectations jumped, which clearly suggests that financial conditions will need to be tightened, the number of respondents expecting higher stock prices one year from today jumped to the highest since November 2021... which incidentally is just when the market topped out during the last cycle before suffering a painful bear market.

Tyler Durden Mon, 03/11/2024 - 12:40

Read More

Continue Reading

Uncategorized

Homes listed for sale in early June sell for $7,700 more

New Zillow research suggests the spring home shopping season may see a second wave this summer if mortgage rates fall
The post Homes listed for sale in…

Published

on

  • A Zillow analysis of 2023 home sales finds homes listed in the first two weeks of June sold for 2.3% more. 
  • The best time to list a home for sale is a month later than it was in 2019, likely driven by mortgage rates.
  • The best time to list can be as early as the second half of February in San Francisco, and as late as the first half of July in New York and Philadelphia. 

Spring home sellers looking to maximize their sale price may want to wait it out and list their home for sale in the first half of June. A new Zillow® analysis of 2023 sales found that homes listed in the first two weeks of June sold for 2.3% more, a $7,700 boost on a typical U.S. home.  

The best time to list consistently had been early May in the years leading up to the pandemic. The shift to June suggests mortgage rates are strongly influencing demand on top of the usual seasonality that brings buyers to the market in the spring. This home-shopping season is poised to follow a similar pattern as that in 2023, with the potential for a second wave if the Federal Reserve lowers interest rates midyear or later. 

The 2.3% sale price premium registered last June followed the first spring in more than 15 years with mortgage rates over 6% on a 30-year fixed-rate loan. The high rates put home buyers on the back foot, and as rates continued upward through May, they were still reassessing and less likely to bid boldly. In June, however, rates pulled back a little from 6.79% to 6.67%, which likely presented an opportunity for determined buyers heading into summer. More buyers understood their market position and could afford to transact, boosting competition and sale prices.

The old logic was that sellers could earn a premium by listing in late spring, when search activity hit its peak. Now, with persistently low inventory, mortgage rate fluctuations make their own seasonality. First-time home buyers who are on the edge of qualifying for a home loan may dip in and out of the market, depending on what’s happening with rates. It is almost certain the Federal Reserve will push back any interest-rate cuts to mid-2024 at the earliest. If mortgage rates follow, that could bring another surge of buyers later this year.

Mortgage rates have been impacting affordability and sale prices since they began rising rapidly two years ago. In 2022, sellers nationwide saw the highest sale premium when they listed their home in late March, right before rates barreled past 5% and continued climbing. 

Zillow’s research finds the best time to list can vary widely by metropolitan area. In 2023, it was as early as the second half of February in San Francisco, and as late as the first half of July in New York. Thirty of the top 35 largest metro areas saw for-sale listings command the highest sale prices between May and early July last year. 

Zillow also found a wide range in the sale price premiums associated with homes listed during those peak periods. At the hottest time of the year in San Jose, homes sold for 5.5% more, a $88,000 boost on a typical home. Meanwhile, homes in San Antonio sold for 1.9% more during that same time period.  

 

Metropolitan Area Best Time to List Price Premium Dollar Boost
United States First half of June 2.3% $7,700
New York, NY First half of July 2.4% $15,500
Los Angeles, CA First half of May 4.1% $39,300
Chicago, IL First half of June 2.8% $8,800
Dallas, TX First half of June 2.5% $9,200
Houston, TX Second half of April 2.0% $6,200
Washington, DC Second half of June 2.2% $12,700
Philadelphia, PA First half of July 2.4% $8,200
Miami, FL First half of June 2.3% $12,900
Atlanta, GA Second half of June 2.3% $8,700
Boston, MA Second half of May 3.5% $23,600
Phoenix, AZ First half of June 3.2% $14,700
San Francisco, CA Second half of February 4.2% $50,300
Riverside, CA First half of May 2.7% $15,600
Detroit, MI First half of July 3.3% $7,900
Seattle, WA First half of June 4.3% $31,500
Minneapolis, MN Second half of May 3.7% $13,400
San Diego, CA Second half of April 3.1% $29,600
Tampa, FL Second half of June 2.1% $8,000
Denver, CO Second half of May 2.9% $16,900
Baltimore, MD First half of July 2.2% $8,200
St. Louis, MO First half of June 2.9% $7,000
Orlando, FL First half of June 2.2% $8,700
Charlotte, NC Second half of May 3.0% $11,000
San Antonio, TX First half of June 1.9% $5,400
Portland, OR Second half of April 2.6% $14,300
Sacramento, CA First half of June 3.2% $17,900
Pittsburgh, PA Second half of June 2.3% $4,700
Cincinnati, OH Second half of April 2.7% $7,500
Austin, TX Second half of May 2.8% $12,600
Las Vegas, NV First half of June 3.4% $14,600
Kansas City, MO Second half of May 2.5% $7,300
Columbus, OH Second half of June 3.3% $10,400
Indianapolis, IN First half of July 3.0% $8,100
Cleveland, OH First half of July  3.4% $7,400
San Jose, CA First half of June 5.5% $88,400

 

The post Homes listed for sale in early June sell for $7,700 more appeared first on Zillow Research.

Read More

Continue Reading

Trending